{
    "2020-01-06": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Stock Sinks",
                        "Market Gains"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-01-01",
                "original_text": "Dogs of the Dow 2020: 10 Dividend Stocks to Watch",
                "features": {
                    "keywords": [
                        "Dogs of the Dow",
                        "Dividend Stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dividend"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-15",
                "original_text": "Md. biotech outlines path for blood cancer drug, including in China",
                "features": {
                    "keywords": [
                        "biotech",
                        "blood cancer drug",
                        "China"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-20",
                "original_text": "New antibiotics struggle to generate sales, pharma companies hurt",
                "features": {
                    "keywords": [
                        "antibiotics",
                        "sales",
                        "pharma companies"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Pfizer Stock Is A Top Pharma Company â€” But Should You Buy It?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Top Pharma Company",
                        "Buy"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "BAVENCIO Significantly Improved Overall Survival in Patients With Locally Advanced or Metastatic Urothelial Carcinoma",
                "features": {
                    "keywords": [
                        "BAVENCIO",
                        "Improved",
                        "Overall Survival",
                        "Urothelial Carcinoma"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "oncology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}